Skye Bioscience SKYE
NASDAQ SKYE
$0.28 -0.03 (-9.68%)
At close: Aug 20, 2026 · 4:00 PM EDT

Skye Bioscience (SKYE) Debt Ratio (2013 - 2026)

Skye Bioscience (SKYE) posted quarterly Debt Ratio of 0.01 for Q1 2026, down 56.33% year-over-year from 0.03 in Q1 2025, and down 74.07% quarter-over-quarter from 0.05 in Q3 2025.

Skye Bioscience (SKYE) Debt Ratio (2013 - 2026) Analysis & Trends

Skye Bioscience (SKYE) has reported Debt Ratio for 10 consecutive years, with 0.01 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Debt Ratio fell 56.33% year-over-year to 0.01; the TTM figure through Mar 2026 stood at 0.01 (down 56.33% YoY), while the FY2024 annual figure was 0.02, down 96.59% from the prior year.
  • Debt Ratio declined to 0.01 in Q1 2026 per SKYE's latest filing, from 0.05 in the prior quarter.
  • Across five years, Debt Ratio topped out at 1.35 in Q1 2023 and bottomed at 0.01 in Q1 2026.
  • Historically, Debt Ratio has averaged 0.3 across 5 years, with a median of 0.09 in 2022.
  • Annual changes were most pronounced in 2022 — Debt Ratio soared 1266.38% — and 2024, when it plunged 96.59%.
  • Skye Bioscience's Debt Ratio stood at 0.88 in 2022, then fell by 17.16% to 0.73 in 2023, then slumped by 96.59% to 0.02 in 2024, then soared by 98.89% to 0.05 in 2025, then sank by 74.07% to 0.01 in 2026.
  • Business Quant data shows SKYE's Debt Ratio at 0.01 in Q1 2026, 0.05 in Q3 2025, and 0.03 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 0.05
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 0.05
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn -
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 0.26
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.47
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 0.03
10 Skye Bioscience 11.17 Mn 11.17 Mn - 0.49

Historic Data

Download Data
DateValue
Mar 31, 2026 0.01
Sep 30, 2025 0.05
Jun 30, 2025 0.03
Mar 31, 2025 0.03
Dec 31, 2024 0.02
Jun 30, 2024 0.07
Mar 31, 2024 0.05
Dec 31, 2023 0.73
Sep 30, 2023 0.40
Mar 31, 2023 1.35
Dec 31, 2022 0.88
Sep 30, 2022 0.17
Jun 30, 2022 0.12
Mar 31, 2022 0.30
Dec 31, 2021 0.15
Sep 30, 2021 0.04
Mar 31, 2021 0.02
Dec 31, 2020 0.04
Sep 30, 2020 0.03
Jun 30, 2020 0.51